Skip to main content
. 2010 Mar 10;48(5):1651–1660. doi: 10.1128/JCM.02250-09

TABLE 1.

In vitro drug testing of antimalarial activity of T3/SAR97276 and artesunate using different drug sensitivity tests

Drug Incubation period (h) Geometric mean IC50 in nM against P. falciparum 3D7 (95% CI)a as determined by using:
MIC HX assay SYBR green pLDH ELISA HRP2 ELISA
T3/SAR97276 48 5.6 4.6 (4-5.2) 77.3 (25.7-232) >1,000 18.5 (14.1-24.3)
72 2 4.5 (3.7-5.6) 2.3 (0.6-9.9) 19.5 (15.3-24.7) 99.3 (50.3-19.6)
72 (w/o drug)b 7.2 8.1 (6.9-9.5) 7.4 (5.9-9.2)
96 h 1.9 1.3 (1.2-1.4) 3.9 (3.6-4.4)
96 (w/o drug) 7.4 5.3 (4.6-6.3) 6.3 (5.7-7)
Artesunate 48 3.7 1.1 (0.8-1.4) 1.9 (1.2-2.8) 2.4 (2.2-2.6) 1.5 (1.4-1.7)
72 1.6 1.2 (0.8-1.6) 1.5 (1.3-1.8) 2.0 (1.1-3.4) 2.5 (1.9-3.3)
72 (w/o drug) 1.8 1.4 (1-2.1) 1.5 (1.4-1.7)
96 1.8 1.1 (0.9-1.5) 1.3 (1.1-1.5)
96 (w/o drug) 1.4 1.4 (1.1-1.8) 1.6 (1.5-1.8)
a

MIC, microscopy; HX, hypoxanthine. Values in boldface do not match the real IC50 (see the text).

b

w/o drug, without drug. In these cases, after 48 h of contact with the drug, infected erythrocytes were washed for drug clearance and then incubated in fresh drug-free culture medium.